Measurement of the type I IFN signature is a useful tool for predicting the subsequent disease activity course.
No takes yet. Share an insight, caveat, or question.
Mai et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: